| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9164573 | Chest | 2005 | 9 Pages |
Abstract
Concern about nonvertebral fracture risk should not strongly influence the decision to use recommended doses of ICS for adult patients with asthma or COPD in managed-care settings in the United States. This study could not evaluate very-high ICS dose, long-term ICS exposure, or vertebral fracture risk.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Catherine B. PhD, Gary A. MSPH, Timothy J. BA, Tanya D. Alfredson, Kourtney J. PhD, Alexander M. MD, DrPH,